Logo image of ALADO.PA

ADOMOS (ALADO.PA) Stock Fundamental Analysis

EPA:ALADO - Euronext Paris - Matif - FR001400UT31 - Common Stock - Currency: EUR

0.028  +0.01 (+26.13%)

Fundamental Rating

1

Taking everything into account, ALADO scores 1 out of 10 in our fundamental rating. ALADO was compared to 73 industry peers in the Real Estate Management & Development industry. While ALADO seems to be doing ok healthwise, there are quite some concerns on its profitability. ALADO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALADO had negative earnings in the past year.
In the past year ALADO had a positive cash flow from operations.
ALADO had negative earnings in 4 of the past 5 years.
ALADO had a positive operating cash flow in each of the past 5 years.
ALADO.PA Yearly Net Income VS EBIT VS OCF VS FCFALADO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M -6M

1.2 Ratios

ALADO has a Return On Assets of -27.58%. This is amonst the worse of the industry: ALADO underperforms 83.56% of its industry peers.
The Return On Equity of ALADO (-37.52%) is worse than 75.34% of its industry peers.
Industry RankSector Rank
ROA -27.58%
ROE -37.52%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALADO.PA Yearly ROA, ROE, ROICALADO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALADO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALADO.PA Yearly Profit, Operating, Gross MarginsALADO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300

More info and screens

4

2. Health

2.1 Basic Checks

ALADO does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ALADO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALADO.PA Yearly Shares OutstandingALADO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
ALADO.PA Yearly Total Debt VS Total AssetsALADO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

2.2 Solvency

ALADO has an Altman-Z score of 0.27. This is a bad value and indicates that ALADO is not financially healthy and even has some risk of bankruptcy.
ALADO's Altman-Z score of 0.27 is on the low side compared to the rest of the industry. ALADO is outperformed by 72.60% of its industry peers.
ALADO has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.28, ALADO is in the better half of the industry, outperforming 73.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z 0.27
ROIC/WACCN/A
WACC4.08%
ALADO.PA Yearly LT Debt VS Equity VS FCFALADO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 2.84 indicates that ALADO has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.84, ALADO is doing good in the industry, outperforming 76.71% of the companies in the same industry.
A Quick Ratio of 2.41 indicates that ALADO has no problem at all paying its short term obligations.
ALADO has a Quick ratio of 2.41. This is in the better half of the industry: ALADO outperforms 79.45% of its industry peers.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 2.41
ALADO.PA Yearly Current Assets VS Current LiabilitesALADO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

ALADO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21784.33%.
ALADO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -67.14%.
Measured over the past years, ALADO shows a very negative growth in Revenue. The Revenue has been decreasing by -24.81% on average per year.
EPS 1Y (TTM)-21784.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2379.44%
Revenue 1Y (TTM)-67.14%
Revenue growth 3Y-36.91%
Revenue growth 5Y-24.81%
Sales Q2Q%-73.6%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALADO.PA Yearly Revenue VS EstimatesALADO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALADO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALADO.PA Price Earnings VS Forward Price EarningsALADO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALADO.PA Per share dataALADO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10K -20K -30K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALADO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADOMOS

EPA:ALADO (6/6/2025, 7:00:00 PM)

0.028

+0.01 (+26.13%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap85.12K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF 0.65
P/B 0.01
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-35780.88
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)0.04
OCFY152.73%
SpS0.59
BVpS5.44
TBVpS-0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.58%
ROE -37.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45.63%
Cap/Sales 126.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.84
Quick Ratio 2.41
Altman-Z 0.27
F-Score3
WACC4.08%
ROIC/WACCN/A
Cap/Depr(3y)78.69%
Cap/Depr(5y)105.37%
Cap/Sales(3y)86.03%
Cap/Sales(5y)71.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21784.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2379.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-67.14%
Revenue growth 3Y-36.91%
Revenue growth 5Y-24.81%
Sales Q2Q%-73.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-92.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-90.25%
OCF growth 3Y-64.61%
OCF growth 5Y-38.02%